Cellosaurus logo
expasy logo

Cellosaurus OACM5.1 C (CVCL_1842)

[Text version]
Cell line name OACM5.1 C
Synonyms OAC-M5.1 C; OAC-M5.1; OACM5-1; OACM5.1; OACM5_1; OACM51
Accession CVCL_1842
Resource Identification Initiative To cite this cell line use: OACM5.1 C (RRID:CVCL_1842)
Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
Population: Caucasian.
Doubling time: ~48 hours (DSMZ=ACC-696).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: CRISPR phenotypic screen.
Omics: Deep exome analysis.
Omics: Deep quantitative proteome analysis.
Omics: DNA methylation analysis.
Omics: Genome sequenced.
Omics: Transcriptome analysis by microarray.
Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
Genome ancestry Source: PubMed=30894373

Origin% genome
African0
Native American0.02
East Asian, North0
East Asian, South0
South Asian1.6
European, North72.08
European, South26.29
Disease Esophageal adenocarcinoma (NCIt: C4025)
Adenocarcinoma of the esophagus (ORDO: Orphanet_99976)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_JX13 (OACM5 1.C SC1)
Sex of cell Female
Age at sampling 47Y
Category Cancer cell line
STR profile Source(s): Cosmic-CLP=1503363; DSMZ=ACC-696; ECACC=11012006; PubMed=20075370

Markers:
AmelogeninX
CSF1PO10,13
D2S133819,24
D3S135816,17
D5S81811,12 (Cosmic-CLP=1503363; DSMZ=ACC-696; ECACC=11012006)
12 (PubMed=20075370)
D7S8208 (Cosmic-CLP=1503363; DSMZ=ACC-696; PubMed=20075370)
8.2 (ECACC=11012006)
D8S117913 (DSMZ=ACC-696)
13,14 (PubMed=20075370)
D13S31711,12
D16S53910,11
D18S5116
D19S43314,15
D21S1128,31
FGA22
Penta D10
Penta E7,14
TH016,9.3
TPOX8
vWA19,20

Run an STR similarity search on this cell line
Publications

PubMed=11407472; DOI=10.1007/s004280000358
de Both N.J., Wijnhoven B.P.L., Sleddens H.F.B.M., Tilanus H.W., Dinjens W.N.M.
Establishment of cell lines from adenocarcinomas of the esophagus and gastric cardia growing in vivo and in vitro.
Virchows Arch. 438:451-456(2001)

PubMed=20075370; DOI=10.1093/jnci/djp499; PMCID=PMC2902814
Boonstra J.J., van Marion R., Beer D.G., Lin L., Chaves P., Ribeiro C., Pereira A.D., Roque L., Darnton S.J., Altorki N.K., Schrump D.S., Klimstra D.S., Tang L.H., Eshleman J.R., Alvarez H., Shimada Y., van Dekken H., Tilanus H.W., Dinjens W.N.M.
Verification and unmasking of widely used human esophageal adenocarcinoma cell lines.
J. Natl. Cancer Inst. 102:271-274(2010)

PubMed=23795680; DOI=10.1111/dote.12095
Boonstra J.J., Tilanus H.W., Dinjens W.N.M.
Translational research on esophageal adenocarcinoma: from cell line to clinic.
Dis. Esophagus 28:90-96(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=27594985; DOI=10.12688/f1000research.7033.1; PMCID=PMC4991527
Contino G., Eldridge M.D., Secrier M., Bower L., Elliott R.F., Weaver J., Lynch A.G., Edwards P.A.W., Fitzgerald R.C.
Whole-genome sequencing of nine esophageal adenocarcinoma cell lines.
F1000Research 5:1336.1-1336.12(2016)

PubMed=28504813; DOI=10.3892/or.2017.5640; PMCID=PMC5492849
Melsens E., De Vlieghere E., Descamps B., Vanhove C., De Wever O., Ceelen W., Pattyn P.
Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection.
Oncol. Rep. 38:71-81(2017)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

PubMed=30971826; DOI=10.1038/s41586-019-1103-9
Behan F.M., Iorio F., Picco G., Goncalves E., Beaver C.M., Migliardi G., Santos R., Rao Y., Sassi F., Pinnelli M., Ansari R., Harper S., Jackson D.A., McRae R., Pooley R., Wilkinson P., van der Meer D.J., Dow D., Buser-Doepner C.A., Bertotti A., Trusolino L., Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature 568:511-516(2019)

PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)

Cross-references
Cell line collections (Providers) DSMZ; ACC-696
ECACC; 11012006
Cell line databases/resources cancercelllines; CVCL_1842
Cell_Model_Passport; SIDM00444
Cosmic-CLP; 1503363
DepMap; ACH-001368
DSMZCellDive; ACC-696
Biological sample resources BioSample; SAMN03473445
CRISP screens repositories BioGRID_ORCS_Cell_line; 970
Chemistry resources GDSC; 1503363
PharmacoDB; OACM51_1176_2019
Encyclopedic resources Wikidata; Q54931676
Gene expression databases ArrayExpress; E-MTAB-3610
GEO; GSM1670290
Polymorphism and mutation databases Cosmic; 1599344
Proteomic databases PRIDE; PXD030304
Sequence databases EGA; EGAS00001000978
Entry history
Entry creation04-Apr-2012
Last entry update10-Sep-2024
Version number32